Royalty Report: Drugs, Pharmaceuticals, Pain – Collection: 2384


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 4


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 4

Primary Industries

  • Drugs
  • Pharmaceuticals
  • Pain

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 2384

License Grant
The Licensor hereby grants to the Licensee an Exclusive License, including under the ProQuest Patent Rights, to make, have made, use, sell, offer to sell and import PQ-1002.
License Property
PQ-1002 is an anesthetic compound. The compound is a pro-drug of the world's best selling anesthetic agent, propofol.  Gabapentin is a analogue. It was originally developed for the treatment of and currently, Gabapentin is widely used to relieve pain, especially neuropathic pain.
Field of Use
The field of use relates to the medical industry.

IPSCIO Record ID: 25850

License Grant
The University granted the Licensee an exclusive license to  make, have made, use, sell, offer to sell, import, have imported, and otherwise exploit Licensed Products and to practice Licensed Methods.  The inventions, generally characterized as High Dose Capsaicin Relieves Neuropathic Pain (or High Dose Capsaicin for Neuropathic Pain) UCSF Case No. SF00-056.
License Property
Patent Rights means the Regents’ interest in any subject matter claimed in or covered by any of the following: Pending U.S. Patent Application Serial No. 08/746,207 entitled Therapeutic Method with Capsaicin and Capsaicin Analogs filed November 6, 1996, the continuation-in-part U.S. Patent Application Serial No. 08/990,633 entitled Transdermal Therapeutic Device and Method with Capsaicin and Capsaicin Analogs filed December 15, 1997 and assigned to The Regents; pending PCT Patent Application Serial No. PCT/US98/25794 of the same title, filed December 8, 1998 and assigned to The Regents; and continuing applications thereof including divisions, substitutions, continuation-in-part applications (but only to the extent however, that claims in the continuation-in-part applications are entitled to the priority filing date of the foregoing applications); any patents issuing on said applications including reissues, reexaminations and extensions; and any corresponding foreign applications or patents based on said applications.
Field of Use
The rights granted apply to the healthcare industry.  Field of Use means all fields and uses.

IPSCIO Record ID: 5728

License Grant
We entered into a non-exclusive, worldwide license agreement with Licensor, an individual,  for U.S. Provisional Patent Application No. 60/006,385 and U.S. Utility Patent Application No. 08/746,207 (U.S. Patent No. 6,248,788) directed to methods of treating neuropathic pain using capsaicin anesthetic, and all applications and patents relating thereto. The licensed technology relates to the use of capsaicin for pain relief. The primary patent underlying the license expires on November 6, 2016. This license agreement makes reference to the August 2001 license agreement between us and Drs. Campbell and Licensor and Mr. Meyer and provides that if Dr. Licensor develops or has any right to any technology under U.S. Patent No. 6,248,788 relating to an injectable product or service using capsaicin and its analogues for pain relief, the technology will be licensed to us pursuant to the terms of the August 2001 license agreement with Drs. Campbell and Licensor and Mr. Meyer.
Field of Use
Field of Use means any human or non-human diagnostic, prophylactic or therapeutic use of the Licensed Patents and Licensed Technology.

IPSCIO Record ID: 5409

License Grant
The Licensor grants an exclusive license to the Licensee to develop and commercialize a variety of biologically active compounds and has patented Know-How for generating chemical compounds having ion channel modulatory properties– used in medicinal chemistry programs.
Field of Use
Field of use shall mean the area of Pain, Pain Management, and all therapeutic, diagnostic or prophylactic uses of Agreement Compounds or any Derivatives thereof as Pain modulators,     including but not limited to, local, topical and/or systemic analgesics and/or anesthetics.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.